Table 3 Economic evaluation methods of included studies
Author, pub year | Type of evaluation | Design | Type of modelling/design | Time horizon | Perspective | Discounting (%) | Uncertainty analysis [# iterations] | Currency and year | Method of CE |
|---|---|---|---|---|---|---|---|---|---|
Permanicha et al. 2015 | CUA and CEA | Modelling | Macro (Markov) | Lifetime | Provider | 3 | Deterministic (one-way) and PSA [1000] | Thai baht, 2013 | WTP |
Anderson et al. 2000 | CEA | Modelling | Pharmacoeconomic analysis | 1 year | Private sector healthcare funder | – | Not stated | Rands, 1999 | Not stated |
Mason et al. 2014 | CEA | Modelling | Macro (Markov) | 10 years | Healthcare provider | 3 | Not stated | Int. dollar, 2010 | Not stated |
Donaldson et al. 2011 | CEA | Modelling | Macro | 10 years | Societal (no productivity loss estimated) | 3 | Not stated | US dollar, 2008 | Not stated |
Yan et al. 2015 | CEA | Empirical | Retrospective | Not stated | Healthcare provider | – | One-way sensitivity [-] | Chinese Yuan, 2008 | WHO 3xGDP |
Bautista LE et al. 2013 | CUA | Modelling | Macro (Markov) | Lifetime | Healthcare system | 3 | One-way sensitivity [–] | US dollar | Not stated |
Anderson et al. 2000 | CUA and CEA | Modelling | Pharmacoeconomic analysis | 3.8 years | Private sector healthcare provider | 5 | Not stated | Rands, 1999 | Not stated |
Basu S et al. 2016 | CUA | Modelling | Microsimulation | Lifetime | Healthcare provider | 3 | PSA [10,000] | US dollar, 2005 | WHO 3xGDP |
Khonputsa et al. 2012 | CUA | Modelling | Macro (Markov) | Lifetime | Healthcare | 3 | PSA [2000] | Thai baht, 2004 | WHO 3xGDP |
Rabus et al. 2005 | CEA | Empirical | Retrospective | 1 year | Government | – | PSA [1000] | Euro, 1999 | Not stated |
Gaziano et al. 2006 | CUA | Modelling | Macro (Markov) | Lifetime | Societal (no productivity loss estimated) | 3 | PSA [Not stated] | US dollar, 2001 | WHO 3xGDP |
Gaziano et al. 2015 | CUA | Modelling | Microsimulation | Lifetime | Healthcare | 3 | Deterministic sensitivity [–] | US dollar, 2013 | WHO 3xGDP |
Li et al. 2015 | CUA and CEA | Modelling | Micro (discrete-event simulation) | Lifetime | Healthcare | 3 | Deterministic (one-way) and PSA [1000] | US dollar, 2013 | WHO 3xGDP |
Ortegon et al. 2012 | CUA | Modelling | Macro (Markov) | Lifetime | Healthcare | 3 | Deterministic (one-way) and PSA [Not stated] | Int. dollar, 2005 | WHO 3xGDP |
Permsuwan et al. 2015 | CUA | Modelling | Macro (Decision tree & Markov) | Lifetime | Societal | 3 | Deterministic (one-way) and PSA [1000] | Thai baht, 2013 | WTP |
Ha et al. 2011 | CUA | Modelling | Macro (Markov) | Lifetime | Societal | 3 | Deterministic (one-way) and PSA [1000] | Vietnamese Dong, 2007 | WHO 3xGDP |
Schulman-Marcus et al. 2010 | CUA | Modelling | Macrosimulation | Lifetime | Societal (no productivity loss & transport estimated) | 3 | Deterministic (one-way) and PSA [Not stated] | US dollar, 2007 | WHO 3xGDP |
Jafar et al. 2011 | CEA | Empirical | RCT | Not stated | Societal | 5 | Bayesian PSA [1000] | US dollar 2007 | WHO 3xGDP |
Choosakulchart et al. 2013 | CUA | Modelling | Macro (Markov) | Lifetime | Societal | 3 | Deterministic (one-way) and PSA [10,000] | Thai baht, 2010 | WTP |
Lakic et al. 2012 | CUA | Modelling | Macro (Markov) | Lifetime | Third party payer | 5 | PSA [10,000] | Serbian dinar, 2009 | WHO 3xGDP |
Pan et al. 2014 | CUA | Modelling | Macro (Markov) | Lifetime | Healthcare | 3 | Deterministic (one-way) and PSA [10,000] | Chinese Yuan, 2011 | WHO 3xGDP |
Wilcox et al. 2015 | CEA | Modelling | Macro (Markov) | 10 years | Healthcare | 3 | Multiway sensitivity analysis | Int. dollar, 2010 | WHO 3xGDP |
Gaziano et al. 2005 | CEA | Modelling | Macro (Markov) | 10 years | Healthcare | 3 | Deterministic (one-way) and PSA [1000] | US dollar, 2001 | WHO 3xGDP |
Amirsadri and Hassani 2015 | CUA and CEA | Modelling | Macro (semi-Markov) | Lifetime | Healthcare | 3 | Deterministic (one-way) and PSA [10,000] | US dollar, 2014 | WHO 3xGDP |
Wu et al. 2014 | CUA | Modelling | Microsimulation | Lifetime | Health system | 3 | Deterministic (one-way) & PSA [1000] | US dollar, 2012 | WHO 3xGDP |
Mejia et al. 2015 | CUA | Modelling | Macro (Markov) | 10 years | Healthcare | 3 | Deterministic (one-way) and PSA [Not stated] | Colombian Peso, 2010 | WHO 3xGDP |
Salomon et al. 2012 | CUA | Modelling | Macro (Markov) | Lifetime | Societal (no productivity loss estimated) | 3 | Not stated | Int. dollar, 2005 | WHO 3xGDP |
Gu et al. 2015 | CUA | Modelling | Macro (Markov) | 10 years | Healthcare | 3 | Deterministic (one-way) and PSA [1000] | Int. dollar, 2015 | WHO 3xGDP |
Nguyen et al. 2016 | CUA | Modelling | Macro (Decision tree and Markov) | 10 years and Lifetime | Health service | 3 | Deterministic (one-way) and PSA [5000] | Int. dollar, 2013 | WTP |
Davies et al. 2013 | CUA | Modelling | Macro (Markov) | Lifetime | Healthcare system | 3 | Deterministic sensitivity analysis [–] | Euros, 2011 | WTP |
Jarungsuccess et al. 2014 | CUA | Modelling | Macro (Markov) | Lifetime | Government and Societal (no productivity loss estimated) | 3 | PSA [5000] | Thai baht, 2013 | WHO 3xGDP |
Wang et al. 2013 | CUA | Modelling | Macro (Markov) | Lifetime | Societal (no productivity loss estimated) | – | Deterministic (one-way) and PSA [1000] | US dollar, 2013 | WHO 3xGDP |
Robberstad et al. 2007 | CUA | Modelling | Macro (Markov) | Lifetime | Healthcare | 3 | Deterministic (one-way) and PSA [5000] | US dollar, 2005 | WHO 3xGDP |
Ngalesoni et al. 2016 | CUA | Modelling | Macro (Markov) | Lifetime | Provider and Societal (no productivity loss estimated) | 3 | Deterministic (one-way) and PSA [Not stated] | US dollar, 2012 | WHO 3xGDP |
Tolla et al. 2016 | CUA | Modelling | Macro (Markov) | Lifetime | Healthcare provider | 3 | Deterministic (one-way) and PSA [1000] | US dollar, 2012 | WHO 3xGDP |
Rubinstein et al. 2010 | CUA | Modelling | Macro (Markov) | 5 years | Healthcare system | 3 | PSA [1000] | Int. dollar, 2007 | WHO 3xGDP |
Basu et al. 2015 | CUA | Modelling | Micro (Discrete-event simulation) | 20 years | Societal (no productivity loss estimated) | 3 | PSA [10,000] | US dollar, 2014 | WHO 3xGDP |
Rosendaal et al. 2010 | CUA | Modelling | Macro (Markov) | 10 years | Healthcare provider | 3 | Deterministic (one-way) and PSA [1000] | US dollar, 2012 | WHO 3xGDP |
Ekwunife et al. 2013 | CUA | Modelling | Macro (Markov) | 30 years | Third party payer | 3 | PSA [1000] | US dollar, 2010 | WTP |
Amirsadri and Sedighi 2017 | CUA and CEA | Modelling | Macro (Markov) | Lifetime | Healthcare provider | 3 | Deterministic (one-way) and PSA [Not stated] | US dollar, 2015 | WHO 3xGDP |
Wang et al. 2017 | CEA | Empirical | RCT | Not stated | Healthcare | – | Not stated | US dollar, 2013 | Not stated |
Polanczyk et al. 2007 | CEA | Modelling | Macro (Decision tree and Markov) | 1 year and lifetime | Private and public health payers | 3 | PSA [10,000] | Brazilian reais, 2003 | Not stated |
Garcia-Pena et al. 2002 | CEA | Empirical | RCT | Not stated | Health service and patient | – | Not stated | Mexican pesos,1998 | Not stated |
Ribeiro et al. 2010 | CUA and CEA | Modelling | Macro (Markov) | 20 years | Public healthcare system | 3 | Deterministic (one-way) and PSA [1000] | US dollar, 2007 | WHO 3xGDP |
Araujo et al. 2008 | CEA | Modelling | Macro (Markov) | 1 and 20 years | Healthcare system | – | Not stated | Brazilian reais, 2005 | Not stated |
Araujo et al. 2007 | CEA | Modelling | Macro (Markov) | 20 years | Healthcare system | 7 | Not stated | Brazilian reais, 2007 | Not stated |
Murray et al. 2003 | CUA | Modelling | Macro (Markov) | Lifetime | Not stated | 3 | Multivariate sensitivity analysis [–] | Int. dollar, | WHO 3xGDP |
Akkazieva et al. 2009 | CUA | Modelling | Macro (Markov) | 10 years | Not stated | – | Not stated | Kyrgygstan Som, 2005 | WHO 3xGDP |
Gonzalez-Diaz et al. 2015 | CEA | Empirical | retrospective | Not stated | Health service provider | – | Deterministic (one-way) and PSA [1000] | US dollar, 2014 | WTP |
Huang and Ren 2010 | CBA | Empirical | Retrospective | Not stated | Healthcare | – | Not stated | Chinese Yuan, 1997 | Not stated |